Free Trial

Ryan Specialty Holdings Inc. (NYSE:RYAN) Receives $75.58 Consensus Target Price from Brokerages

Ryan Specialty logo with Finance background

Ryan Specialty Holdings Inc. (NYSE:RYAN - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twelve analysts that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $75.58.

A number of equities research analysts recently weighed in on the company. UBS Group increased their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Royal Bank Of Canada decreased their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a report on Friday, February 21st. Morgan Stanley boosted their price target on Ryan Specialty from $78.00 to $80.00 and gave the company an "overweight" rating in a research note on Monday, May 19th. Wells Fargo & Company lowered their price objective on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Finally, Barclays dropped their target price on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a report on Friday, April 11th.

Get Our Latest Stock Analysis on RYAN

Insider Buying and Selling

In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,377 shares of the business's stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the transaction, the executive vice president now directly owns 1,117 shares in the company, valued at $73,543.28. The trade was a 92.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director David P. Bolger sold 5,000 shares of the firm's stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the sale, the director now directly owns 71,467 shares in the company, valued at approximately $5,059,863.60. This represents a 6.54% decrease in their position. The disclosure for this sale can be found here. 52.21% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of RYAN. Mutual of America Capital Management LLC boosted its stake in shares of Ryan Specialty by 1.7% in the 4th quarter. Mutual of America Capital Management LLC now owns 56,203 shares of the company's stock valued at $3,606,000 after purchasing an additional 914 shares in the last quarter. Truist Financial Corp boosted its position in Ryan Specialty by 7.2% in the fourth quarter. Truist Financial Corp now owns 5,688 shares of the company's stock valued at $365,000 after buying an additional 381 shares in the last quarter. CIBC Private Wealth Group LLC grew its stake in shares of Ryan Specialty by 6,911.0% during the fourth quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock worth $48,036,000 after buying an additional 774,718 shares during the last quarter. Sanctuary Advisors LLC increased its holdings in shares of Ryan Specialty by 1.2% during the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock worth $1,045,000 after buying an additional 188 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Ryan Specialty by 3.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 974,451 shares of the company's stock valued at $62,521,000 after acquiring an additional 36,264 shares during the last quarter. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Stock Performance

Shares of RYAN stock traded up $0.43 on Tuesday, reaching $67.09. The stock had a trading volume of 641,722 shares, compared to its average volume of 995,446. Ryan Specialty has a 12 month low of $53.92 and a 12 month high of $77.16. The firm has a market capitalization of $17.61 billion, a price-to-earnings ratio of 197.16, a P/E/G ratio of 1.78 and a beta of 0.70. The firm's 50-day moving average is $68.75 and its two-hundred day moving average is $68.23. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 3.45.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, hitting analysts' consensus estimates of $0.39. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The firm had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. During the same quarter in the previous year, the business earned $0.35 earnings per share. The business's revenue was up 25.0% compared to the same quarter last year. On average, research analysts expect that Ryan Specialty will post 2.29 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.72%. The ex-dividend date of this dividend was Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is presently 141.18%.

Ryan Specialty Company Profile

(Get Free Report

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Articles

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines